Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2021/06/15/sage-plummets-after-drug-trial-results

6/15/2021 11:07 AM

The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 16.5% to trade at $60.85 at last check, following lackluster Phase 3 test results for the biotechnology company's depression drug, Zuranolon...

Sage Stock Slips Amid Biogen Deal Critique

https://www.schaeffersresearch.com/content/news/2020/12/01/sage-stock-slips-amid-biogen-deal-critique

12/1/2020 11:57 AM

The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...

The Options Strategy Perfect for Volatile Markets

https://www.schaeffersresearch.com/content/options/2020/03/27/the-options-strategy-perfect-for-volatile-markets

3/27/2020 12:45 PM

A long volatility/ straddle strategy might be a good idea for the current roller-coaster market environment we're experiencing. Having a set allocation of your portfolio with these types of trades can...

Stocks Hesitate with Trade and OPEC in Focus

https://www.schaeffersresearch.com/content/ezines/2019/12/05/stocks-hesitate-with-trade-and-opec-in-focus

12/5/2019 11:54 AM

Stocks are generally searching for direction at midday, as investors consider a muddied outlook for U.S.-China trade talks. The Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq...

SAGE Stock Gets Boost on FDA Approval

https://www.schaeffersresearch.com/content/news/2019/03/20/sage-stock-gets-boost-on-fda-approval

3/20/2019 9:37 AM

The shares of SAGE Therapeutics Inc (NASDAQ:SAGE) are up 2% at $159.20, after its postpartum depression (PPD) drug, Zulresso, was approved by the Food and Drug Administration (FDA). Some experts' ne...

PEOPLE ALSO SEARCH FOR